Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Income towards Parent Company: 2016-2024

Historic Income towards Parent Company for Protagonist Therapeutics (PTGX) over the last 9 years, with Dec 2024 value amounting to $275.2 million.

  • Protagonist Therapeutics' Income towards Parent Company fell 18.46% to -$39.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.9 million, marking a year-over-year decrease of 73.15%. This contributed to the annual value of $275.2 million for FY2024, which is 448.54% up from last year.
  • As of FY2024, Protagonist Therapeutics' Income towards Parent Company stood at $275.2 million, which was up 448.54% from -$79.0 million recorded in FY2023.
  • Protagonist Therapeutics' Income towards Parent Company's 5-year high stood at $275.2 million during FY2024, with a 5-year trough of -$127.4 million in FY2022.
  • For the 3-year period, Protagonist Therapeutics' Income towards Parent Company averaged around $22.9 million, with its median value being -$79.0 million (2023).
  • As far as peak fluctuations go, Protagonist Therapeutics' Income towards Parent Company crashed by 73.81% in 2021, and later soared by 448.54% in 2024.
  • Protagonist Therapeutics' Income towards Parent Company (Yearly) stood at -$72.4 million in 2020, then plummeted by 73.81% to -$125.8 million in 2021, then fell by 1.27% to -$127.4 million in 2022, then surged by 38.02% to -$79.0 million in 2023, then skyrocketed by 448.54% to $275.2 million in 2024.